![The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet](https://www.thelancet.com/cms/attachment/2059ef4d-75ee-40cc-b912-9b0d536a1edc/gr1_lrg.jpg)
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
![Oxford Cancer Analytics secures £3 million Seed investment led by Eka Ventures – UK Tech Investment News by Deal Lite Oxford Cancer Analytics secures £3 million Seed investment led by Eka Ventures – UK Tech Investment News by Deal Lite](https://www.uktechnews.info/wp-content/uploads/2023/01/Oxford-Cancer-Analytics-Team-1-1050x750.jpg)
Oxford Cancer Analytics secures £3 million Seed investment led by Eka Ventures – UK Tech Investment News by Deal Lite
![Oxford Cancer Analytics secures £1.28 million Seed investment from investors including Cancer Research UK and Civilisation Ventures – UK Tech Investment News by Deal Lite Oxford Cancer Analytics secures £1.28 million Seed investment from investors including Cancer Research UK and Civilisation Ventures – UK Tech Investment News by Deal Lite](https://www.uktechnews.info/wp-content/uploads/2021/09/Co-Founders-Oxford-Cancer-Analytics.jpg)
Oxford Cancer Analytics secures £1.28 million Seed investment from investors including Cancer Research UK and Civilisation Ventures – UK Tech Investment News by Deal Lite
![DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection - ScienceDirect DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004223006879-fx1.jpg)
DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection - ScienceDirect
![Leading provider of high technology products and services for research and industry - Oxford Instruments Leading provider of high technology products and services for research and industry - Oxford Instruments](https://www.oxinst.com/assets/components/phpthumbof/cache/ProteoxS_Homepage_Banner_02_1.64f6d3195e0ae6f645746362dfab3352.jpg)
Leading provider of high technology products and services for research and industry - Oxford Instruments
![Virtual reality for the observation of oncology models (VROOM): immersive analytics for oncology patient cohorts | Scientific Reports Virtual reality for the observation of oncology models (VROOM): immersive analytics for oncology patient cohorts | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-15548-1/MediaObjects/41598_2022_15548_Fig1_HTML.png)